BioMarin Pharmaceutical Operating Expenses 2010-2024 | BMRN
BioMarin Pharmaceutical operating expenses for the twelve months ending September 30, 2024 were $2.430B, a 11.66% increase year-over-year.
- BioMarin Pharmaceutical annual operating expenses for 2023 were $2.261B, a 16.17% increase from 2022.
- BioMarin Pharmaceutical annual operating expenses for 2022 were $1.946B, a 0.93% increase from 2021.
- BioMarin Pharmaceutical annual operating expenses for 2021 were $1.929B, a 1.3% increase from 2020.